I've heard that FX-322 phase 2a clinical trial is currently about 3/4 of the way complete as of August 5, 2020. It is still not known if the study will be complete by September 30, 2020 as there is still a need for additional participants. A trial study takes 210 days, so we are looking at the summer of 2021 before we hear any news from Frequency Therapeutics on phase 2a.
If successful AND if needed, my take is that Phase 3 would be in 2022.
Curiously, I've often wondered about the numerical term "322", theorizing that their goal for market must be March, 2022. Still could be, I suppose.